GHRP-2 and GHRP-6 Stimulate GH Release Through Different Intracellular Mechanisms
GHRP-2 increases intracellular cAMP and synergizes with GHRH additively, while GHRP-6 stimulates GH release without raising cAMP, confirming they use partially different signaling pathways.
Quick Facts
What This Study Found
GHRP-2 increased intracellular cAMP (like GHRH) while GHRP-6 released GH without raising cAMP, revealing partially different mechanisms despite similar GH-releasing outcomes.
Key Numbers
How They Did This
In vitro study using partially purified sheep somatotrophs and rat pituitary cells. Intracellular cAMP and GH release were measured after treatment with GHRP-2, GHRP-6, and GRF (GHRH).
Why This Research Matters
Understanding the signaling differences between GHRPs helps predict their clinical behavior, drug interactions, and optimal combination strategies.
The Bigger Picture
This mechanistic difference between GHRP-2 and GHRP-6 helps explain their different clinical profiles and potencies, informing which peptide is best suited for different therapeutic scenarios.
What This Study Doesn't Tell Us
In vitro study using animal pituitary cells. Species differences may exist. Partially purified somatotrophs may not fully represent in vivo conditions.
Questions This Raises
- ?What explains GHRP-6's ability to release GH without raising cAMP?
- ?Does the cAMP-independent mechanism of GHRP-6 translate to different clinical effects than GHRP-2?
Trust & Context
- Key Stat:
- GHRP-2 uses cAMP; GHRP-6 does not Despite similar GH-releasing outcomes, GHRP-2 and GHRP-6 use partially different intracellular signaling pathways
- Evidence Grade:
- Moderate in vitro evidence from two species with clear mechanistic distinction between the two peptides.
- Study Age:
- Published in 1996, this study provided important mechanistic distinctions between GHRPs that inform current understanding.
- Original Title:
- The effects of GH-releasing peptide-6 (GHRP-6) and GHRP-2 on intracellular adenosine 3',5'-monophosphate (cAMP) levels and GH secretion in ovine and rat somatotrophs.
- Published In:
- The Journal of endocrinology, 148(2), 197-205 (1996)
- Authors:
- Wu, D(2), Chen, C(2), Zhang, J(2), Bowers, C Y, Clarke, I J
- Database ID:
- RPEP-00395
Evidence Hierarchy
Frequently Asked Questions
Why does it matter that GHRP-2 and GHRP-6 work differently?
Even though both peptides release growth hormone through the same receptor, they activate partially different intracellular signaling cascades. This could explain differences in their potency, side effects, and how well they combine with other treatments.
What is cAMP?
Cyclic AMP (cAMP) is a key cellular messenger molecule. When GHRH activates pituitary cells, it raises cAMP, which triggers GH release. GHRP-2 also raises cAMP, but GHRP-6 bypasses this pathway entirely while still releasing GH.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-00395APA
Wu, D; Chen, C; Zhang, J; Bowers, C Y; Clarke, I J. (1996). The effects of GH-releasing peptide-6 (GHRP-6) and GHRP-2 on intracellular adenosine 3',5'-monophosphate (cAMP) levels and GH secretion in ovine and rat somatotrophs.. The Journal of endocrinology, 148(2), 197-205.
MLA
Wu, D, et al. "The effects of GH-releasing peptide-6 (GHRP-6) and GHRP-2 on intracellular adenosine 3',5'-monophosphate (cAMP) levels and GH secretion in ovine and rat somatotrophs.." The Journal of endocrinology, 1996.
RethinkPeptides
RethinkPeptides Research Database. "The effects of GH-releasing peptide-6 (GHRP-6) and GHRP-2 on..." RPEP-00395. Retrieved from https://rethinkpeptides.com/research/wu-1996-the-effects-of-ghreleasing
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.